Jakarta: Kementerian Kesehatan Republik Indonesia

(1)

63

DAFTAR PUSTAKA

1. Pedoman Nasional Pelayanan Kedokteran Tatalaksana Tuberkulosis. Jakarta:

Kementerian Kesehatan Republik Indonesia; 2020.

2. Houben RMGJ, Dodd PJ. The Global Burden of Latent Tuberculosis Infection:

A Re-estimation Using Mathematical Modelling. PLoS Med. 2016 Oct;13(10):e1002152.

3. Profil Kesehatan Indonesia Tahun 2020. Jakarta: Kementerian Kesehatan Republik Indonesia; 2021.

4. Bates M, Marais BJ, Zumla A. Tuberculosis Comorbidity with Communicable and Noncommunicable Diseases. Cold Spring Harb Perspect Med [Internet].

2015 Nov [cited 2022 May 30];5(11):a017889. Available from:

http://perspectivesinmedicine.cshlp.org/lookup/doi/10.1101/cshperspect.a017 889

5. Petunjuk Teknis Penatalaksanaan Tuberkulosis Resisten Obat di Indonesia.

Jakarta: Direktorat Pencegahan dan Pengendalian Penyakit Kementerian Kesehatan Republik Indonesia; 2020.

6. World Health Organization. Global tuberculosis report 2020 [Internet].

Geneva: World Health Organization; 2020 [cited 2022 Mar 28]. Available from: https://apps.who.int/iris/handle/10665/336069

7. Izhar MD, Butar MB, Hidayati F, Ruwayda R. Predictors and health-related quality of life with short form-36 for multidrug-resistant tuberculosis patients in Jambi, Indonesia: A case-control study. Clin Epidemiol Glob Health [Internet]. 2021 Oct [cited 2022 Jun 17];12:100872. Available from:

https://linkinghub.elsevier.com/retrieve/pii/S2213398421001809

8. World Health Organization. WHO consolidated guidelines on drug-resistant tuberculosis treatment [Internet]. Geneva: World Health Organization; 2019

[cited 2022 Apr 25]. 99 p. Available from:

https://apps.who.int/iris/handle/10665/311389

9. Tiberi S, Utjesanovic N, Galvin J, Centis R, D’Ambrosio L, van den Boom M, et al. Drug resistant TB – latest developments in epidemiology, diagnostics and management. Int J Infect Dis [Internet]. 2022 Mar [cited 2022 Apr

25];S1201971222001655. Available from:

10. Soeroto AY, Pratiwi C, Santoso P, Lestari BW. Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: A retrospective cohort study. Marotta C, editor. PLOS ONE

(2)

[Internet]. 2021 Feb 8 [cited 2022 Apr 26];16(2):e0246284. Available from:

https://dx.plos.org/10.1371/journal.pone.0246284

11. The Republic of Indonesia Joint External Monitoring Mission for Tuberculosis.

12. Allué-Guardia A, García JI, Torrelles JB. Evolution of Drug-Resistant Mycobacterium tuberculosis Strains and Their Adaptation to the Human Lung Environment. Front Microbiol [Internet]. 2021 Feb 4 [cited 2022 Apr

26];12:612675. Available from:

https://www.frontiersin.org/articles/10.3389/fmicb.2021.612675/full

13. Drug-Resistant Tuberculosis: A Survival Guide for Clinicians. 3rd ed. Curry International Tuberculosis Center and California Department of Public Health;

2016.

14. Hunter RL, Actor JK, Hwang SA, Karev V, Jagannath C. Pathogenesis of post primary tuberculosis: immunity and hypersensitivity in the development of cavities. Ann Clin Lab Sci. 2014;44(4):365–87.

15. Ryndak MB, Laal S. Mycobacterium tuberculosis Primary Infection and Dissemination: A Critical Role for Alveolar Epithelial Cells. Front Cell Infect Microbiol [Internet]. 2019 Aug 21 [cited 2022 Jun 21];9:299. Available from:

https://www.frontiersin.org/article/10.3389/fcimb.2019.00299/full

16. Dheda K, Gumbo T, Gandhi NR, Murray M, Theron G, Udwadia Z, et al.

Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis. Lancet Respir Med. 2014 Apr;2(4):321–38.

17. Wani RLS. Clinical manifestations of pulmonary and extra-pulmonary tuberculosis. South Sudan Med J. 2013 Aug;6(3).

18. Pambudi I, Lukitosari E, Dewi RK, Permata Y. Petunjuk Teknis Penatalaksanaan Tuberkulosis Resistan Obat di Indonesia. Jakarta: Direktorat Jenderal Pencegahan dan Pengendalian Penyakit Kementerian Kesehatan Republik Indonesia; 2020.

19. Peraturan Mentri Kesehatan Republik Indonesia No.67 Tahun 2016 Tentang Penanggulangan Tuberkulosis. 2016.

20. Nasution SD. Malnutrisi dan Anemia Pada Penderita Tuberkulosis Paru. J Kedokt Unila. 2015 Nov;4(8):36.

21. Wijaya I. Tuberkulosis Paru pada Penderita Diabetes Melitus. Cermin Dunia Kedokt. 2015;42(6):412–7.

22. Mahadita GW, Somia IA. Patogenesis dan diagnosis immune reconstitution inflammatory syndrome tuberculosis. Intisari Sains Medis. 2020;11(3):1492–9.

(3)

23. Fitriya L, Artanti KD. Treatment Outcomes of Multidrug Resistant Tuberculosis Patients in East Java from 2014 to 2017. J Berk Epidemiol [Internet]. 2020 May 31 [cited 2022 Apr 27];8(2):141. Available from:

https://e-journal.unair.ac.id/JBE/article/view/14200

24. Madansein R, Parida S, Padayatchi N, Singh N, Master I, Naidu K, et al.

Surgical Treatment of Complications of Pulmonary Tuberculosis, including Drug-Resistant Tuberculosis. Int J Infect Dis [Internet]. 2015 Mar [cited 2022

Apr 27];32:61–7. Available from:

25. Masturoh I, Anggita T. N. Metodologi Penelitian Kesehatan. 1st ed. Jakarta:

26. Prijatni I, Rahayu S. Kesehatan Reproduksi dan Keluarga Berencana. 1st ed.

Jakarta: Kementerian Kesehatan Republik Indonesia; 2016.

27. Dorland WAN. Kamus Saku Kedokteran Dorland. 29th ed. Singapore:

Elsevier; 2015.

28. Meisartika R, Safrianto Y. Karakteristik Gaya Kepemimpinan Terhadap Kinerja Kerja Pegawai Kantor Camat Meurebo Kabupaten Aceh Barat. J Ilm Akunt Dan Keuang. 2021;4(2).

29. Harjatmo TP, M. Par’i H, Wiyono S. Penilaian Status Gizi. 1st ed. Jakarta:

30. Lianzi I, Pitaloka E. Hubungan Pengetahuan Tentang Rokok dan Perilaku Merokok Pada Staf Administrasi Universitas Esa Unggul. J Inohim. 2014;2(1).

31. Jagirdar J. Mycobacterial Diseases. In: Pulmonary Pathology [Internet].

Elsevier; 2008 [cited 2022 May 24]. p. 204–18. Available from:

https://linkinghub.elsevier.com/retrieve/pii/B9780443067419500173

32. Hunter RL. Pathology of post primary tuberculosis of the lung: an illustrated critical review. Tuberc Edinb Scotl. 2011 Nov;91(6):497–509.

33. Nuraini, Naziah, Zainaro MA. Pengalaman Putus Obat pada Klien TB yang Mendapatkan Pengobatan OAT dengan Strategi DOTS di RS Umum Kabupaten Tangerang Tahun 2016. J JKFT Univ Muhammadiyah Tangerang.

2018;3.

34. Anisah A, Sumekar DW, Budiarti E. Hubungan Demografi dan Komorbid dengan Kejadian Tuberkulosis Resisten Obat (TB RO). J Ilm Kesehat Sandi Husada [Internet]. 2021 Dec 31 [cited 2022 Nov 12];10(2):568–74. Available from: https://akper-sandikarsa.e-journal.id/JIKSH/article/view/655

(4)

35. Putri VA. Profil Pasien Tuberculosis Multi Drug Resistance (TB-MDR) di Poliklinik TB-MDR RSUD Arifin Achmad Provinsi Riau Periode April 2013- Juni 2014. J Online Mhs FK UNRI. 2015;1(2).

36. Heriqbaldi AZ, Setiabudi RJ, Meliana RY. First-Line Anti-Tuberculosis Drug Resistance Pattern. J Respirasi [Internet]. 2022 Jan 30 [cited 2022 Nov 15];8(1):1. Available from: https://e-journal.unair.ac.id/JR/article/view/28630 37. Siahaan AG, Polii EG, Ongkowijaya J. Profil Pasien Tuberkulosis Dengan

Multi-Drug Resistance (MDR) di RSUD Prof. Dr. R. D. Kandou Periode Agustus 2015-Agustus 2016. J E-Clin. 2016;4(2):1–7.

38. Rohman H. Pola Spasial Persebaran Kasus Tuberkulosis Paru Terhadap Kepadatan Penduduk. In: PROSIDING: Seminar Nasional Rekam Medis dan Informasi Kesehatan. 1st ed. Yogyakarta: Asosiasi Perguruan Tinggi Rekam Medis dan Manajemen Informasi Kesehatan; 2018.

39. Santy D, Siagian P, Sinaga BY, Eyanoer PC. Hubungan Indeks Massa Tubuh Dengan Waktu Konversi Sputum Pada Pasien TB MDR Yang Menjalani Pengobatan Dengan Panduan Jangka Pendek di RSUP H. Adam Malik Medan.

J Respirologi Indones. 2020;40(4):225–31.

40. Wibowo A, Burhan E, Putra AC. Pola Resistansi Kuman Tuberkulosis dan Regimen Pengobatan Pada Pasien Tuberkulosis Resisten Obat Di Rumah Sakit Pusat Rujukan Respirasi Nasional Persahabatan Jakarta. J Kedokt Unila.

2021;5(1):1–6.

41. Pratomo IP, Burhan E, Tambunan V. Malnutrisi dan Tuberkulosis. J Indones Med Assoc. 2012;62(6):230–6.

42. Soeroto AY, Nurhayati RD, Purwiga A, Lestari BW, Pratiwi C, Santoso P, et al. Factors associated with treatment outcome of MDR/RR-TB patients treated with shorter injectable based regimen in West Java Indonesia. Quinn F, editor.

PLOS ONE [Internet]. 2022 Jan 28 [cited 2022 Dec 16];17(1):e0263304.

Available from: https://dx.plos.org/10.1371/journal.pone.0263304

43. Wang MG, Huang WW, Wang Y, Zhang YX, Zhang MM, Wu SQ, et al.

Association between tobacco smoking and drug-resistant tuberculosis. Infect Drug Resist [Internet]. 2018 Jun [cited 2022 Nov 15];Volume 11:873–87.

Available from: https://www.dovepress.com/association-between-tobacco- smoking-and-drug-resistant-tuberculosis-peer-reviewed-article-IDR

44. Novianti, Simarmata OS, Lolong DB. Pemanfaatan Tes Cepat Molekuler (TCM) GenExpert Sebagai Alat Diagnostik TB Paru di RSUD Wangaya Kota Denpasar. J Ekol Kesehat. 2019;18(3).

(5)

45. Ikrom FM, Rahmanisa S. Intervensi untuk Mencegah Tuberkulosis Resisten Obat. J Kedokt Unila. 2016;5(4).

46. Widiastuti E, Subroto Y, Promono D. Determinan Kejadian Multi-drug Resistant Tuberculosis di Rumah Sakit Dr. Sardjito Yogyakarta. Ber Kedokt Masy. 2017;33(7):325–30.

47. Sarwani D, Nurlaela S, Zahrotul A I. Faktor Risiko Multi-Drug Resistance (MDR-TB). J Kesehat Masy. 2012;8(1):60–6.

48. Bayissa A, Demissie M, Biru M, Akalu Z. Proportion and trend of primary resistance among Multidrug resistant Tuberculosis patients in Ethiopia. J Clin Tuberc Mycobact Dis [Internet]. 2022 May [cited 2022 Dec 19];27:100315.

Available from:

49. Abdul JBPAA, Adegbite BR, Ndanga MED, Edoa JR, Mevyann RC, Mfoumbi GRAI, et al. Resistance patterns among drug-resistant tuberculosis patients and trends-over-time analysis of national surveillance data in Gabon, Central Africa. Infection [Internet]. 2022 Oct 28 [cited 2022 Dec 8]; Available from:

https://link.springer.com/10.1007/s15010-022-01941-5

50. Petunjuk Teknis Pemeriksaan Line Probe Assay (LPA) Lini Dua. Direktorat Jenderal Pencegahan dan Pengendalian Penyakit Kementerian Kesehatan Republik Indonesia; 2020.

51. Varghese B, Al-Hajoj S. First Insight Into the Fluoroquinolone and Aminoglycoside Resistance of Multidrug-Resistant Mycobacterium tuberculosis in Saudi Arabia. Am J Trop Med Hyg [Internet]. 2017 May 3 [cited

2022 Dec 23];96(5):1066–70. Available from:

https://ajtmh.org/doi/10.4269/ajtmh.16-0579

52. Tasnim T, Tarafder S, Alam FM, Sattar H, Mostofa Kamal SM. Pre- Extensively Drug Resistant Tuberculosis (Pre-XDR-TB) among Pulmonary Multidrug Resistant Tuberculosis (MDR-TB) Patients in Bangladesh. J Tuberc Res [Internet]. 2018 [cited 2022 Dec 23];06(03):199–206. Available from:

http://www.scirp.org/journal/doi.aspx?DOI=10.4236/jtr.2018.63018

53. Siregar SR. Extensively Drug Resistant Tubeculosis (XDR TB). J Averrous.

2019;5(2):26–43.

54. Fretes F de, Mangma YE, Dese DC. Analisa Peran Pengawas Minum Obat (PMO) dalam Mendampingi Pasien Tuberkulosis di Kota Kupang. J Keperawatan Muhammadiyah. 2021;6(3).

55. Fatmawati U, Kusmiati T. Characteristics and the Side Effects of New MDR- TB Treatment in the Dr. Soetomo Hospital during 2016. J Respirasi. 2017;3(3).

(6)

56. Soedarsono, Rialdi A. Tuberculosis Drug-Induced Liver Injury. J Respirasi.

2020;6(2):49–54.

57. Tupasi TE, Garfin AMCG, Kurbatova EV, Mangan JM, Orillaza-Chi R, Naval LC, et al. Factors Associated with Loss to Follow-up during Treatment for Multidrug-Resistant Tuberculosis, the Philippines, 2012–2014. Emerg Infect Dis [Internet]. 2016 Mar [cited 2022 Dec 23];22(3):491–502. Available from:

http://wwwnc.cdc.gov/eid/article/22/3/15-1788_article.htm

58. Kasron K, Rahayu YSE, Sobirin. Karaktetistik Pasien TB-MDR di RSUD Cilacap Periode Januari-Desember 2017. Media Ilmu Kesehat. 2019;8(2):171–

9.

59. Saktiawati AMI, Subronto YW. Influence of Diabetes Mellitus on the Development of Multi Drug Resistant Tuberculosis in Yogyakarta. Indones J Intern Med. 2018;50(1).